Product overview
Introducing FormularyDecisions PIE Market Insights
FDA guidance and the PIE Act of 2022 allow biopharma companies to share key product information with payers and other health care decision-makers before FDA approval. Cencora helps clients build effective PIE strategies, and its new PIE Market Insights offering from FormularyDecisions gives biopharma teams visibility into HCDM preferences to guide what to communicate, how to engage, and when to do it during the pre-approval window.
Helping you shape more effective PIE strategies
- Plan for a powerful launch with an interactive dashboard that delivers annually refreshed, product-agnostic PIE market research insights drawn from Cencora's proprietary Managed Care Network (MCN) and payer advisor panel, giving you a powerful foundation for every pre-approval conversation.
- Stay ahead of the curve by augmenting your existing insights with Express Surveys, which allows you to send custom questions directly to HCDMs for real-time answers when you need them most.
